These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
487 related articles for article (PubMed ID: 12941770)
1. Increased beta-cell apoptosis prevents adaptive increase in beta-cell mass in mouse model of type 2 diabetes: evidence for role of islet amyloid formation rather than direct action of amyloid. Butler AE; Janson J; Soeller WC; Butler PC Diabetes; 2003 Sep; 52(9):2304-14. PubMed ID: 12941770 [TBL] [Abstract][Full Text] [Related]
2. Diabetes due to a progressive defect in beta-cell mass in rats transgenic for human islet amyloid polypeptide (HIP Rat): a new model for type 2 diabetes. Butler AE; Jang J; Gurlo T; Carty MD; Soeller WC; Butler PC Diabetes; 2004 Jun; 53(6):1509-16. PubMed ID: 15161755 [TBL] [Abstract][Full Text] [Related]
3. Beta-cell deficit due to increased apoptosis in the human islet amyloid polypeptide transgenic (HIP) rat recapitulates the metabolic defects present in type 2 diabetes. Matveyenko AV; Butler PC Diabetes; 2006 Jul; 55(7):2106-14. PubMed ID: 16804082 [TBL] [Abstract][Full Text] [Related]
4. Replication increases beta-cell vulnerability to human islet amyloid polypeptide-induced apoptosis. Ritzel RA; Butler PC Diabetes; 2003 Jul; 52(7):1701-8. PubMed ID: 12829636 [TBL] [Abstract][Full Text] [Related]
5. Toxic human islet amyloid polypeptide (h-IAPP) oligomers are intracellular, and vaccination to induce anti-toxic oligomer antibodies does not prevent h-IAPP-induced beta-cell apoptosis in h-IAPP transgenic mice. Lin CY; Gurlo T; Kayed R; Butler AE; Haataja L; Glabe CG; Butler PC Diabetes; 2007 May; 56(5):1324-32. PubMed ID: 17353506 [TBL] [Abstract][Full Text] [Related]
6. Islet amyloid polypeptide (IAPP) transgenic rodents as models for type 2 diabetes. Matveyenko AV; Butler PC ILAR J; 2006; 47(3):225-33. PubMed ID: 16804197 [TBL] [Abstract][Full Text] [Related]
7. Successful versus failed adaptation to high-fat diet-induced insulin resistance: the role of IAPP-induced beta-cell endoplasmic reticulum stress. Matveyenko AV; Gurlo T; Daval M; Butler AE; Butler PC Diabetes; 2009 Apr; 58(4):906-16. PubMed ID: 19151199 [TBL] [Abstract][Full Text] [Related]
8. beta-cell glucokinase deficiency and hyperglycemia are associated with reduced islet amyloid deposition in a mouse model of type 2 diabetes. Andrikopoulos S; Verchere CB; Terauchi Y; Kadowaki T; Kahn SE Diabetes; 2000 Dec; 49(12):2056-62. PubMed ID: 11118007 [TBL] [Abstract][Full Text] [Related]
9. Intra- and extracellular amyloid fibrils are formed in cultured pancreatic islets of transgenic mice expressing human islet amyloid polypeptide. de Koning EJ; Morris ER; Hofhuis FM; Posthuma G; Höppener JW; Morris JF; Capel PJ; Clark A; Verbeek JS Proc Natl Acad Sci U S A; 1994 Aug; 91(18):8467-71. PubMed ID: 8078905 [TBL] [Abstract][Full Text] [Related]
10. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Butler AE; Janson J; Bonner-Weir S; Ritzel R; Rizza RA; Butler PC Diabetes; 2003 Jan; 52(1):102-10. PubMed ID: 12502499 [TBL] [Abstract][Full Text] [Related]
11. Dual role of interleukin-1β in islet amyloid formation and its β-cell toxicity: Implications for type 2 diabetes and islet transplantation. Park YJ; Warnock GL; Ao Z; Safikhan N; Meloche M; Asadi A; Kieffer TJ; Marzban L Diabetes Obes Metab; 2017 May; 19(5):682-694. PubMed ID: 28058779 [TBL] [Abstract][Full Text] [Related]
12. An in vitro model of early islet amyloid polypeptide (IAPP) fibrillogenesis using human IAPP-transgenic mouse islets. Henson MS; Buman BL; Jordan K; Rahrmann EP; Hardy RM; Johnson KH; O'Brien TD Amyloid; 2006 Dec; 13(4):250-9. PubMed ID: 17107885 [TBL] [Abstract][Full Text] [Related]
13. Spontaneous diabetes mellitus in transgenic mice expressing human islet amyloid polypeptide. Janson J; Soeller WC; Roche PC; Nelson RT; Torchia AJ; Kreutter DK; Butler PC Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7283-8. PubMed ID: 8692984 [TBL] [Abstract][Full Text] [Related]
14. [Islet amyloid and diabetes mellitus type 2]. Höppener JW; Nieuwenhuis MG; Vroom TM; Lips CJ Ned Tijdschr Geneeskd; 2000 Oct; 144(42):1995-2000. PubMed ID: 11072517 [TBL] [Abstract][Full Text] [Related]
15. Human islet amyloid polypeptide transgenic mice: in vivo and ex vivo models for the role of hIAPP in type 2 diabetes mellitus. Höppener JW; Jacobs HM; Wierup N; Sotthewes G; Sprong M; de Vos P; Berger R; Sundler F; Ahrén B Exp Diabetes Res; 2008; 2008():697035. PubMed ID: 18497871 [TBL] [Abstract][Full Text] [Related]
16. Induction of endoplasmic reticulum stress-induced beta-cell apoptosis and accumulation of polyubiquitinated proteins by human islet amyloid polypeptide. Huang CJ; Haataja L; Gurlo T; Butler AE; Wu X; Soeller WC; Butler PC Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1656-62. PubMed ID: 17911343 [TBL] [Abstract][Full Text] [Related]
17. Islet amyloid polypeptide: a review of its biology and potential roles in the pathogenesis of diabetes mellitus. O'Brien TD; Butler PC; Westermark P; Johnson KH Vet Pathol; 1993 Jul; 30(4):317-32. PubMed ID: 8212454 [TBL] [Abstract][Full Text] [Related]
18. Spontaneous diabetes in hemizygous human amylin transgenic mice that developed neither islet amyloid nor peripheral insulin resistance. Wong WP; Scott DW; Chuang CL; Zhang S; Liu H; Ferreira A; Saafi EL; Choong YS; Cooper GJ Diabetes; 2008 Oct; 57(10):2737-44. PubMed ID: 18633116 [TBL] [Abstract][Full Text] [Related]
19. Islet amyloid polypeptide (IAPP) and pancreatic islet amyloid deposition in diabetic and non-diabetic patients. Narita R; Toshimori H; Nakazato M; Kuribayashi T; Toshimori T; Kawabata K; Takahashi K; Masukura S Diabetes Res Clin Pract; 1992 Jan; 15(1):3-14. PubMed ID: 1541232 [TBL] [Abstract][Full Text] [Related]
20. Extensive islet amyloid formation is induced by development of Type II diabetes mellitus and contributes to its progression: pathogenesis of diabetes in a mouse model. Höppener JW; Oosterwijk C; Nieuwenhuis MG; Posthuma G; Thijssen JH; Vroom TM; Ahrén B; Lips CJ Diabetologia; 1999 Apr; 42(4):427-34. PubMed ID: 10230646 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]